Technical Analysis for MLNT - Melinta Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.02 4.08% 0.04
MLNT closed up 4.08 percent on Friday, January 18, 2019, on 75 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical MLNT trend table...

Date Alert Name Type % Chg
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Narrow Range Bar Range Contraction 4.08%
Jan 17 NR7 Range Contraction 4.08%
Jan 17 NR7-2 Range Contraction 4.08%
Jan 17 Wide Bands Range Expansion 4.08%
Jan 17 Down 3 Days in a Row Weakness 4.08%
Jan 17 Down 4 Days in a Row Weakness 4.08%
Jan 16 1,2,3 Retracement Bearish Bearish Swing Setup 2.00%
Jan 16 Boomer Sell Setup Bearish Swing Setup 2.00%

Older signals for MLNT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Melinta Therapeutics, Inc., formerly Cempra, Inc., is a clinical-stage pharmaceutical company. The Company focuses on developing differentiated antibiotics for the acute care and community settings to meet medical needs in the treatment of bacterial infectious diseases. Its product, solithromycin (CEM-101), which is a macrolide and fluoroketolide, is being developed in oral capsules, intravenous (IV) and suspension formulations for the treatment of community-acquired bacterial pneumonia (CABP). Solithromycin has therapeutic potential and activity to target pathogenic bacteria. It has completed two pivotal Phase III trials for solithromycin to treat CABP, as of December 31, 2016. Its Fusidic acid is an antibiotic and the Company is exploring its use for the long-term oral treatment for refractory bone and joint infections (BJI), including prosthetic joint infections, which are caused by staphylococci, including S. aureus, methicillin-resistant S. aureus and other gram-positive bacteria.
Is MLNT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.25
52 Week Low 0.64
Average Volume 619,389
200-Day Moving Average 4.6604
50-Day Moving Average 1.6648
20-Day Moving Average 0.9681
10-Day Moving Average 1.041
Average True Range 0.1401
ADX 41.52
+DI 13.6637
-DI 23.0495
Chandelier Exit (Long, 3 ATRs ) 0.8397
Chandelier Exit (Short, 3 ATRs ) 1.0603
Upper Bollinger Band 1.2042
Lower Bollinger Band 0.732
Percent B (%b) 0.61
BandWidth 48.775953
MACD Line -0.1681
MACD Signal Line -0.2264
MACD Histogram 0.0583
Fundamentals Value
Market Cap 53.56 Million
Num Shares 52.5 Million
EPS -1.89
Price-to-Earnings (P/E) Ratio -0.54
Price-to-Sales 6.92
Price-to-Book 0.80
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.11
Resistance 3 (R3) 1.11 1.07 1.10
Resistance 2 (R2) 1.07 1.05 1.08 1.09
Resistance 1 (R1) 1.05 1.04 1.06 1.05 1.08
Pivot Point 1.01 1.01 1.02 1.02 1.01
Support 1 (S1) 0.99 0.99 1.00 0.99 0.96
Support 2 (S2) 0.95 0.98 0.96 0.95
Support 3 (S3) 0.93 0.95 0.95
Support 4 (S4) 0.93